Merck (MRK) Adds $15B to Buyback Program

Go back to Merck (MRK) Adds $15B to Buyback Program

Merck (MRK) Tops Q1 EPS by 6c; Lowers FY13 EPS Outlook; Boosts Buyback

May 1, 2013 7:03 AM EDT

Merck & Co., Inc. (NYSE: MRK) reported Q1 EPS of $0.85, $0.06 better than the analyst estimate of $0.79. Revenue for the quarter came in at $10.7 million versus the consensus estimate of $11.09 million.

Sees FY2013 EPS of $3.45 - $3.55, versus the consensus of $3.63 and prior expectations of $3.60 to $3.70.... More